Po-674-03 intravenous sotalol for acute conversion of intra-atrial-reentrant-tachycardia in adults with congenital heart disease

Intra-atrial-reentrant-tachycardia (IART) is a common source of morbidity in adults with congenital heart disease (ACHD). Most patients (pts) that present with IART are treated with direct current cardioversion (DCCV). There is limited data on the efficacy of intravenous (IV) anti-arrhythmics for acute conversion of IART in the ACHD population.